Atreca

Home » Atreca

IPO

Atreca

Biopharmaceutical

We are a biopharmaceutical company utilizing our differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types.

Symbol

BCEL

Price Range
$16.00 - $18.00

Final Shares
7,350,000

Anticipated Date
June 20, 2019

Underwriters
COWEN AND COMPANY, LLC

This offering is no longer available

To view the prospectus for Atreca IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253